2010 Annual Scientific Meeting and Exposition 2010 Annual ...

Monday Morning MAY 3Satellite Symposium6:00 AM - 7:30 AM • Trianon BallroomTargeting Endothelial Dysfunction in HypertensiveCardiovascular Disease: Why, When, and HowChairperson: Thomas D. Giles, MD, New Orleans, LAProgram Agenda:6:00 AM Introduction: New Evidence for Targeting CriticalMechanisms in Hypertensive Heart DiseaseThomas D. Giles, MD6:25 AM Race-Specific Differences in EndothelialDysfunction: Relevance to Management ofHypertensionR. Preston Mason, PhD, Boston, MA6:50 AM Targeting Endothelial Dysfunction in theManagement of Cardiovascular DiseaseAlan H. Gradman, MD, Pittsburgh, PA7:15 AM Panel Discussion and Concluding RemarksThomas D. Giles, MDLearning Objectives:• Describe the role of nitric oxide in endothelialdysfunction and in the pathogenesis ofhypertension, and hypertensive cardiovasculardisease, including LVH and heart failure• Evaluate the relationship between oxidative stressand endothelial function and its relevance to themanagement of hypertensive patients• Identify pre-clinical and clinical evidencesupporting the concept that there are race-baseddifferences in endothelial function which mayhave clinical ramifications• Analyze the pharmacologic differences amongβ-blockers, including those with vasodilatingproperties, and outline the evidence for theclinical impact of these properties, especially ontolerability and efficacyBreakfast will be served at 5:45 AM in theTrianon Ballroom.Supported by an educational grant from Forest Pharmaceuticals, Inc.81